Variable number of tandem repeat of the 5′-flanking region of type-C human natriuretic peptide receptor gene influences blood pressure levels in obesity-associated hypertension

Hypertension Research

Volumn 27, Issue 10, 2004, Pages 711-716

  Aoi, Noriko ^a   Soma, Masayoshi ^a   Nakayama, Tomohiro ^a   Rahmutula, Dolkun ^a   Kosuge, Kotoko ^a   Izumi, Yoichi ^a   Matsumoto, Koichi ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Essential hypertension; Mutation; Natriuretic peptide; Receptor; Variable number of tandem repeat

Indexed keywords

CHOLESTEROL; CREATININE; NATRIURETIC PEPTIDE TYPE C; URIC ACID;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DNA FLANKING REGION; ESSENTIAL HYPERTENSION; FEMALE; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PHENOTYPE; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; TRANSCRIPTION INITIATION SITE; URIC ACID BLOOD LEVEL; VARIABLE NUMBER OF TANDEM REPEAT;

5' FLANKING REGION; ADULT; ALLELES; BLOOD PRESSURE; CASE-CONTROL STUDIES; DIASTOLE; FEMALE; GENETIC MARKERS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MINISATELLITE REPEATS; OBESITY; PHENOTYPE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RECEPTORS, ATRIAL NATRIURETIC FACTOR; SYSTOLE;

EID: 11044222057     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.27.711     Document Type: Article

References (28)

1. Kangawa K, Tawaragi Y, Oikawa S, et al: Identification of rat gamma atrial natriuretic polypeptide and characterization of the cDNA encoding its precursor. Nature 1984; 312: 152-155.
2. Sudoh T, Kangawa K, Minamino N, Matsuo H: A new natriuretic peptide in porcine brain. Nature 1988; 332: 78-81.
3. Sudoh T, Minamino N, Kangawa K, Matsuo H: C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain. Biochem Biophys Res Commun 1990; 168: 863-870.
4. Porter JG, Arfsten A, Fuller F, Miller JA, Gregory LC, Lewicki JA: Isolation and functional expression of the human atrial natriuretic peptide clearance receptor cDNA. Biochem Biophys Res Commun 1990; 171: 796-803.
5. Fuller F, Porter JG, Arfsten AE, et al: Atrial natriuretic peptide clearance receptor: complete sequence and functional expression of cDNA clones. J Biol Chem 1988; 263: 9395-9401.
6. Engel AM, Schoenfeld JR, Lowe DG: A single residue determines the distinct pharmacology of rat and human natriuretic peptide receptor-C. J Biol Chem 1994; 269: 17005-17008.
7. Chinkers M, Garbers DL: Signal transduction by guanylyl cyclases. Annu Rev Biochem 1991; 60: 553-575.
8. Chang M-S, Lowe DG, Lewis M, Hellmiss R, Chen E, Goeddel DV: Differential activation by atrial and brain natriuretic peptides of two different receptor guanylate cyclases. Nature 1989; 341: 68-72.
9. Koller KJ, Lowe DG, Bennett GL, et al: Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP). Science 1991; 252: 120-123.
10. Needleman P, Greenwald JE: Atriopeptin: a cardiac hormone intimately involved in fluid, electrolyte, and blood-pressure homeostasis. N Engl J Med 1986; 314: 828-834.
11. Martin ER, Lewicki JA, Scarborough RM, Ballermann BJ: Expression and regulation of ANP receptor subtypes in rat renal glomeruli and papillae. Am J Physiol 1989; 257: F649-F657.
12. Khurana ML, Pandey KN: Receptor-mediated stimulatory effect of atrial natriuretic factor, brain natriuretic peptide, and C-type natriuretic peptide on testosterone production in purified mouse Leydig cells: activation of cholesterol side-chain cleavage enzyme. Endocrinology 1993; 133: 2141-2149.
13. Sarzani R, Paci VM, Zingaretti CM, et al: Fasting inhibits natriuretic peptides clearance receptor expression in rat adipose tissue. J Hypertens 1995; 13: 1241-1246.
14. Dessi-Fulgheri P, Sarzani R, Tamburrini P, et al: Plasma atrial natriuretic peptide and natriuretic peptide receptor gene expression in adipose tissue of normotensive and hypertensive obese patients. J Hypertens 1997; 15: 1695-1699.
15. Sarzani R, Dessi-Fulgheri P, Paci VM, Espinosa E, Rappelli A: Expression of natriuretic peptide receptors in human adipose and other tissues. J Endocrinol Invest 1996; 19: 581-585.
16. Dessi-Fulgheri P, Sarzani R, Serenelli M, et al: Low calorie diet enhances renal, hemodynamic, and humoral effects of exogenous atrial natriuretic peptide in obese hypertensives. Hypertension 1999; 33: 658-662.
17. Sarzani R, Dessi-Fulgheri P, Salvi F, et al: A novel promoter variant of the natriuretic peptide clearance receptor gene is associated with lower atrial natriuretic peptide and higher blood pressure in obese hypertensives. J Hypertens 1999; 17: 1301-1305.
18. Anand-Srivastava, MB: Enhanced expression of inhibitory guanine nucleotide regulatory protein in spontaneously hypertensive rats: relationship to adenylate cyclase inhibition. Biochem J 1992; 288: 79-85.
19. Rahmutula D, Nakayama T, Soma M, et al: Association study between the variants of the human ANP gene and essential hypertension. Hypertens Res 2001; 24: 291-294.
20. Rahmutula D, Nakayama T, Soma M, et al: An insertion/deletion polymorphism in intron 18 of the type B human natriuretic peptide receptor gene is not associated with cerebral infarction. Hypertens Res 2000; 23: 173-176.
21. Nakayama T, Soma M, Rahmutula D, Ozawa Y, Kanmatsuse K: Isolation of the 5′-flanking region of genes by thermal asymmetric interlaced polymerase chain reaction. Med Sci Monit 2001; 7: 345-349.
22. Nakayama T, Soma M, Takahashi Y, Izumi Y, Kanmatsuse K, Esumi M: Association analysis of CA repeat polymorphism of the endothelial nitric oxide synthase gene with essential hypertension in Japanese. Clin Genet 1997; 51: 26-30.
23. Nakayama T, Soma M, Takahashi Y, Rehemudula D, Kanmatsuse K, Furuya K: Functional deletion mutation of the 5′-flanking region of the type A human natriuretic peptide receptor gene and its association with essential hypertension and left ventricular hypertrophy in the Japanese. Circ Res 2000; 86: 841-845.
24. Yanaka N, Kotera J, Omori K: Isolation and characterization of the 5′-flanking regulatory region of the human natriuretic peptide receptor C gene. Endocrinology 1998; 139: 1389-1400.
25. Rocchini AP: Cardiovascular regulation in obesity-induced hypertension. Hypertension 1992; 19 (Suppl 1): I56-I60.
26. Ferrannini E: The haemodynamics of obesity: a theoretical analysis. J Hypertens 1992; 10: 1417-1423.
27. Cohen D, Koh GY, Nikonova LN, Porter JG, Maack T: Molecular determinants of the clearance function of type C receptors of natriuretic peptides. J Biol Chem 1996; 271: 9863-9869.
28. Dessi-Fulgheri P, Sarzani R, Tamburrini P, et al: Plasma atrial natriuretic peptide and natriuretic peptide receptor gene expression in adipose tissue of normotensive and hypertensive obese patients. Hypertension 1997; 15: 1695-1699.